|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
2021 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
|
 |
|
$2450.00 |
| |
|
|
|
2021 Global Blood Banking Market Overview - Facilities, Test Volumes, and Sales Forecasts for Typing, Grouping and Infectious Disease Screening Tests by Country
This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
2021 Spain Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
|
|
|
$2450.00 |
| |
|
|
|
Blood Banking: Major Suppliers Strategic Assessments
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants....
|
|
|
$2450.00 |
| |
|
|
|
Global Diagnostics Market Dynamics and Trends
The report provides an approximately 55-page worldwide strategic overview of the in vitro diagnostics market, including: - Five-year reagent and instrument sales forecasts for major testing locations (hospitals, commercial/private laboratories, physician offices/group practices, blood center, personal testing and others and major laboratory disciplines (blood typing/grouping, chemist/immunoassay, coagulation, hematology/flow cytometry, histology/cytology, microbiology/serology, urinalysis and others).
- Five-year worldwide sales projections for the most dynamic market segments, such as molecular diagnostics, infectious diseases, tumor markers, and personal testing are developed....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Strategic Directions
For each company, the report provides insightful strategic assessments, including:- Business, new product development, and marketing strategies.
- Anticipated acquisitions, joint ventures, and divestitures....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Marketing Tactics
For each company, the analysis presents: |
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Collaborations
For each company, the report analyzes:- Major joint venture, distribution, O.E....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Company Business Organizations and Senior Management
For each company, the report provides:- History of the diagnostics business evolution important to the understanding of the companys culture management mentality and strategies.
- Most recent significant acquisitions, divestitures and organizational changes....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies R&D Expenditures and Major Programs
For each company, the report provides:- R&D budget, research facilities, and staff.
- New technologies, systems, and applications in development, including their specifications and anticipated introduction dates....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Technological Know-How
For each company, the report analyzes:- Internally developed and acquired in vitro diagnostics.
- Know-how in biotechnology, engineering, electronics and other related fields....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Facilities and Employees
For each company, the analyses present:- Location and size of administrative, manufacturing, and R&D facilities in the U.S....
|
|
|
$2450.00 |
| |
|
|
|
Abbott: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Abbott, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 114 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Bayer Diabetes: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Bayer Diabetes, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 108 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Beckman Coulter: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Beckman Coulter, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 97 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Becton Dickinson: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Becton Dickinson, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 95 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
bioMerieux: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market
A strategic assessment of bioMerieux, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 41 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Bio-Rad: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Bio-Rad, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 30 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
|